Tranexamic Acid Dosing and Frequency
For trauma patients with active bleeding or at risk of significant hemorrhage, administer tranexamic acid as a 1 g intravenous bolus over 10 minutes, followed by a 1 g infusion over 8 hours, initiated within 3 hours of injury. 1, 2
Standard Dosing Regimen
The evidence-based dosing protocol is:
- Loading dose: 1 g IV over 10 minutes
- Maintenance dose: 1 g IV infusion over 8 hours
- Critical timing: Must be administered within 3 hours of injury
This regimen is supported by the landmark CRASH-2 trial and remains the current standard prescription across multiple international guidelines 1, 2, 1. The 2025 Anaesthesia guideline explicitly states "1g bolus within the first hour then 1g/8h" 1.
Timing is Critical
Do not administer tranexamic acid beyond 3 hours after injury - this is a hard stop. The treatment effect disappears after 3 hours (RR 1.00), and administration beyond this window is associated with increased risk of death from hemorrhage (RR 1.44,95% CI 1.12-1.84) 1, 2.
The benefit decreases by approximately 10% for every 15-minute delay in administration 3. Early treatment within 1 hour provides maximum benefit with a 32% reduction in bleeding deaths (RR 0.68) 2.
Context-Specific Dosing
Postpartum Hemorrhage
For postpartum hemorrhage, WHO strongly recommends:
- First dose: 1 g IV over 10 minutes
- Second dose: 1 g IV if bleeding continues after 30 minutes OR restarts within 24 hours
- Must be given within 3 hours of birth 3
Hemophilia (Dental Procedures)
FDA-approved dosing for hemophiliacs undergoing tooth extraction:
- Pre-extraction: 10 mg/kg IV single dose immediately before procedure
- Post-extraction: 10 mg/kg IV 3-4 times daily for 2-8 days 4
Renal Impairment
Dose adjustments are mandatory for renal dysfunction 4:
- Serum creatinine 1.36-2.83 mg/dL: 10 mg/kg twice daily
- Serum creatinine 2.83-5.66 mg/dL: 10 mg/kg once daily
- Serum creatinine >5.66 mg/dL: 10 mg/kg every 48 hours OR 5 mg/kg every 24 hours
Alternative Dosing Considerations
While the standard 1 g + 1 g/8h regimen is most widely validated, some evidence suggests higher doses may benefit specific populations. The STAAMP trial explored repeated dosing up to 3 g total in hypotensive patients 1. However, a 2024 comparative analysis found equivalent 28-day mortality across 1 g bolus only, 1 g + 1 g infusion, and 2 g bolus groups, suggesting single bolus administration may be preferable to avoid infusion complexity 5.
Administration Technique
Infuse no faster than 1 mL/minute to avoid hypotension 4. The drug can be mixed with most IV solutions (electrolytes, carbohydrates, amino acids, dextran) and heparin, but should NOT be mixed with blood or penicillin-containing solutions 4.
Safety Profile
Tranexamic acid does not increase overall thromboembolic risk when used appropriately 2. However, administration beyond 1 day duration or beyond 8 hours post-injury is associated with increased thromboembolic events 6. The incidence of seizures is low (0.6% vs 0.4% placebo) but dose-dependent, with higher rates seen with cardiac surgery doses 2, 7.
Critical contraindication: Do not use in subarachnoid hemorrhage due to risk of cerebral edema and infarction 4.